(12 intermediate revisions by 2 users not shown) | |||
Line 85: | Line 85: | ||
<div class="title_picture"> | <div class="title_picture"> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2018/0/0e/T--Bielefeld-CeBiTec--hands_vk.png" style="width:100%"> |
</div> | </div> | ||
Line 96: | Line 96: | ||
<article> | <article> | ||
We thank all companies and other sponsors for their financial and substantial support, without whose help our project would not have been possible in its current form. | We thank all companies and other sponsors for their financial and substantial support, without whose help our project would not have been possible in its current form. | ||
− | + | </article> | |
<h2>Gold Sponsors</h2> | <h2>Gold Sponsors</h2> | ||
<figure role="group"> | <figure role="group"> | ||
<a href="https://www.stockmeier.com/en/" target="_blank"><img class="figure fifty" src="https://static.igem.org/mediawiki/2018/2/2f/T--Bielefeld-CeBiTec--ES--Partners--Stockmeier-Gruppe.png"></a> | <a href="https://www.stockmeier.com/en/" target="_blank"><img class="figure fifty" src="https://static.igem.org/mediawiki/2018/2/2f/T--Bielefeld-CeBiTec--ES--Partners--Stockmeier-Gruppe.png"></a> | ||
</figure> | </figure> | ||
− | The STOCKMEIER Group is known throughout Europe as a reliable supplier of chemical products. By upholding this aspiration, it has grown from a regional trading company to an international group with over 1,300 employees. Today the STOCKMEIER Group is made up of companies that provide distribution, manufacturing and various services related to chemicals – in more than 40 locations around the world. Today, Peter Stockmeier leads the family business in the third generation. Sustainable and long-term relationships to customers and suppliers are a main building block of success. As well as the engagement of the employees. The STOCKMEIER Group offers apprentices jobs in various departments for decades. Furthermore STOCKMEIER supports scientific projects of young talents, e.g. in the framework of iGEM. | + | <article> |
− | + | The STOCKMEIER Group is known throughout Europe as a reliable supplier of chemical products. By upholding this aspiration, it has grown from a regional trading company to an international group with over 1,300 employees. Today the STOCKMEIER Group is made up of companies that provide distribution, manufacturing and various services related to chemicals – in more than 40 locations around the world. Today, Peter Stockmeier leads the family business in the third generation. Sustainable and long-term relationships to customers and suppliers are a main building block of success. As well as the engagement of the employees. The STOCKMEIER Group offers apprentices jobs in various departments for decades. Furthermore, STOCKMEIER supports scientific projects of young talents, e.g. in the framework of iGEM. | |
+ | </article> | ||
+ | <figure role="group"> | ||
+ | <a href="http://www.emdmillipore.com/" target="_blank"><img class="figure fifty" src="https://static.igem.org/mediawiki/parts/9/90/T--Bielefeld-CeBiTec--ES--MilliporeSigma.jpeg"></a> | ||
+ | </figure> | ||
+ | <article> | ||
+ | MilliporeSigma is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of €15.0 billion in 66 countries. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials. | ||
+ | </article> | ||
<h2>Silver Sponsors</h2> | <h2>Silver Sponsors</h2> | ||
Line 135: | Line 142: | ||
− | |||
− | |||
− | |||
− | |||
− | |||
+ | <br> | ||
<h2>Bronze Sponsors</h2> | <h2>Bronze Sponsors</h2> | ||
Line 148: | Line 151: | ||
<div class="row"> | <div class="row"> | ||
<div class="column_One_Third"> | <div class="column_One_Third"> | ||
− | <figure role="group"> | + | <figure role="group" style="margin:0;"> |
<a href="https://www.sparkasse-bielefeld.de/de/home.html" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/7/7c/T--Bielefeld-CeBiTec--ES--Partners--Sparkasse-Bielefeld.jpeg"></a> | <a href="https://www.sparkasse-bielefeld.de/de/home.html" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/7/7c/T--Bielefeld-CeBiTec--ES--Partners--Sparkasse-Bielefeld.jpeg"></a> | ||
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Two_Third"> | <div class="column_Two_Third"> | ||
− | <figure role="group"> | + | <figure role="group" style="margin:0;"> |
<a href="https://www.jowat.com/en/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/7/72/T--Bielefeld-CeBiTec--ES--Partners--Jowat.png"></a> | <a href="https://www.jowat.com/en/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/7/72/T--Bielefeld-CeBiTec--ES--Partners--Jowat.png"></a> | ||
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Three_Third"> | <div class="column_Three_Third"> | ||
− | <figure role="group"> | + | <figure role="group" style="margin:0;"> |
<img class="figure hundred" src="https://static.igem.org/mediawiki/2018/b/be/T--Bielefeld-CeBiTec--ES--Partners--QIAGEN.jpeg"> | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/b/be/T--Bielefeld-CeBiTec--ES--Partners--QIAGEN.jpeg"> | ||
</figure> | </figure> | ||
Line 167: | Line 170: | ||
<div class="row"> | <div class="row"> | ||
<div class="column_One_Third"> | <div class="column_One_Third"> | ||
− | <figure role="group"> | + | <figure role="group" style="margin:0;"> |
<a href="http://www.weissbiotech.com/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/5/55/T--Bielefeld-CeBiTec--ES--Partners--WeissBioTech.gif"></a> | <a href="http://www.weissbiotech.com/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/5/55/T--Bielefeld-CeBiTec--ES--Partners--WeissBioTech.gif"></a> | ||
</figure> | </figure> | ||
</div> | </div> | ||
− | <div class="column_Two_Third"> | + | <div class="column_Two_Third" style="margin:0;"> |
<figure role="group"> | <figure role="group"> | ||
<a href="https://www.symrise.com/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/0/02/T--Bielefeld-CeBiTec--ES--Partners--symrise.jpeg"></a> | <a href="https://www.symrise.com/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/0/02/T--Bielefeld-CeBiTec--ES--Partners--symrise.jpeg"></a> | ||
Line 177: | Line 180: | ||
</div> | </div> | ||
<div class="column_Three_Third"> | <div class="column_Three_Third"> | ||
− | <figure role="group"> | + | <figure role="group" style="margin:0;"> |
<img class="figure hundred" src="https://static.igem.org/mediawiki/2018/6/6d/T--Bielefeld-CeBiTec--ES--Partners--CYANAGEN.jpeg"> | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/6/6d/T--Bielefeld-CeBiTec--ES--Partners--CYANAGEN.jpeg"> | ||
</figure> | </figure> | ||
</div> | </div> | ||
</div> | </div> | ||
− | + | ||
− | <img class="figure | + | <div class="row"> |
− | </figure> | + | <div class="column_One_Half"> |
− | + | <figure role="group" style="margin:0;"> | |
+ | <a href="https://www.zymoresearch.eu/" target="_blank"><img class="figure fourty" src="https://static.igem.org/mediawiki/2018/c/cb/T--Bielefeld-CeBiTec--ES--Partners--ZYMO-RESEARCH.jpeg"></a> | ||
+ | </figure> | ||
+ | </div> | ||
+ | <div class="column_Two_Half"> | ||
+ | <figure role="group" style="margin:0;"> | ||
+ | <a href="https://www.promega.ca/" target="_blank"><img class="figure fourty" src="https://static.igem.org/mediawiki/2018/9/9c/PromegaLogo.jpeg"></a> | ||
+ | </figure> | ||
+ | </div> | ||
+ | </div> | ||
+ | <br> | ||
Line 197: | Line 210: | ||
<div class="row"> | <div class="row"> | ||
<div class="column_One_Third"> | <div class="column_One_Third"> | ||
− | <figure role="group"> | + | <figure role="group" style="margin:0;"> |
<a href="https://www.cebitec.uni-bielefeld.de/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/6/69/T--Bielefeld-CeBiTec--ES--Partners--CeBiTec.png"></a> | <a href="https://www.cebitec.uni-bielefeld.de/" target="_blank"><img class="figure hundred" src="https://static.igem.org/mediawiki/2018/6/69/T--Bielefeld-CeBiTec--ES--Partners--CeBiTec.png"></a> | ||
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Two_Third"> | <div class="column_Two_Third"> | ||
− | <figure role="group"> | + | <figure role="group" style="margin:0;"> |
<img class="figure hundred" src="https://static.igem.org/mediawiki/2018/a/ab/T--Bielefeld-CeBiTec--ES--Partners--Carl-Roth.png"> | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/a/ab/T--Bielefeld-CeBiTec--ES--Partners--Carl-Roth.png"> | ||
</figure> | </figure> | ||
</div> | </div> | ||
<div class="column_Three_Third"> | <div class="column_Three_Third"> | ||
− | <figure role="group"> | + | <figure role="group" style="margin:0;"> |
<img class="figure hundred" src="https://static.igem.org/mediawiki/2018/2/2e/T--Bielefeld-CeBiTec--ES--Partners--Zierold-Stiftung.jpeg"> | <img class="figure hundred" src="https://static.igem.org/mediawiki/2018/2/2e/T--Bielefeld-CeBiTec--ES--Partners--Zierold-Stiftung.jpeg"> | ||
</figure> | </figure> |
Latest revision as of 04:32, 8 November 2018
Sponsors and partners